Drugs / Alkaline glycine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04738422 | Sep 2020 → Jul 2028 expected | lower respiratory tract disorder | Indiana University | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alkaline glycine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04738422 ↗ |
| Route | Inhaled | “Subjects will inhale alkaline glycine via nebulizer.” NCT04738422 ↗ |